Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Jonsson

Showing results (281-290 of 314) with videos related to

Pageof 32
Sort By:
Journal of Proteome Research|September 7, 2010
Time-dependent proteomic iTRAQ analysis of nasal lavage of hairdressers challenged by persulfateMonica H Kåredal, Harriet Mortstedt, Marina C Jeppsson, et al.
Leukemia|July 11, 2008
Dic(9;20)(p13;q11) in childhood acute lymphoblastic leukaemia is related to low cellular resistance to asparaginase, cytarabine and corticosteroidsG Lönnerholm, A Nordgren, B-M Frost, et al.
Experimental Brain Research|January 1, 1989
Immunohistochemical and behavioral analysis of spinal lesions induced by a substance P antagonist and protection by thyrotropin releasing hormoneJ Freedman, T Hökfelt, C Post, et al.
The Journal of Clinical Psychiatry|November 26, 2002
Cognition-enhancing effect of vagus nerve stimulation in patients with Alzheimer's disease: a pilot studyMagnus J C Sjögren, Per T O Hellström, Michael A G Jonsson, et al.
British Journal of Haematology|July 25, 2003
Increased in vitro cellular drug resistance is related to poor outcome in high-risk childhood acute lymphoblastic leukaemiaBritt-Marie Frost, Peter Nygren, Göran Gustafsson, et al.
Medrxiv : the Preprint Server for Health Sciences|June 9, 2020
Antihypertensive medication uses and serum ACE2 levels: ACEIs/ARBs treatment does not raise serum levels of ACE2Valur Emilsson, Elias F Gudmundsson, Thor Aspelund, et al.
Blood|June 26, 2004
Translocation t(12;21) is related to in vitro cellular drug sensitivity to doxorubicin and etoposide in childhood acute lymphoblastic leukemiaBritt-Marie Frost, Erik Forestier, Göran Gustafsson, et al.
Blood|February 7, 2002
Precise quantification of minimal residual disease at day 29 allows identification of children with acute lymphoblastic leukemia and an excellent outcomeCharlotte Nyvold, Hans O Madsen, Lars P Ryder, et al.
Journal of Neural Transmission|January 1, 1987
Effects of acute and chronic treatment with imipramine on 5-hydroxytryptamine nerve cell groups and on bulbospinal 5-hydroxytryptamine/substance P/thyrotropin releasing hormone immunoreactive neurons in the rat. A morphometric and microdensitometric analysisI Kitayama, A M Janson, K Fuxe, et al.
European Journal of Haematology|August 23, 2011
Pneumocystis jiroveci pneumonia prophylaxis during maintenance therapy influences methotrexate/6-mercaptopurine dosing but not event-free survival for childhood acute lymphoblastic leukemiaMette Levinsen, Diana Shabaneh, Cathrine Bohnstedt, et al.
Pageof 32

Showing results (281-290 of 314) with videos related to

Sort By:
Pageof 32
Journal of Proteome Research|September 7, 2010
Time-dependent proteomic iTRAQ analysis of nasal lavage of hairdressers challenged by persulfateMonica H Kåredal, Harriet Mortstedt, Marina C Jeppsson, et al.
Leukemia|July 11, 2008
Dic(9;20)(p13;q11) in childhood acute lymphoblastic leukaemia is related to low cellular resistance to asparaginase, cytarabine and corticosteroidsG Lönnerholm, A Nordgren, B-M Frost, et al.
Experimental Brain Research|January 1, 1989
Immunohistochemical and behavioral analysis of spinal lesions induced by a substance P antagonist and protection by thyrotropin releasing hormoneJ Freedman, T Hökfelt, C Post, et al.
The Journal of Clinical Psychiatry|November 26, 2002
Cognition-enhancing effect of vagus nerve stimulation in patients with Alzheimer's disease: a pilot studyMagnus J C Sjögren, Per T O Hellström, Michael A G Jonsson, et al.
British Journal of Haematology|July 25, 2003
Increased in vitro cellular drug resistance is related to poor outcome in high-risk childhood acute lymphoblastic leukaemiaBritt-Marie Frost, Peter Nygren, Göran Gustafsson, et al.
Medrxiv : the Preprint Server for Health Sciences|June 9, 2020
Antihypertensive medication uses and serum ACE2 levels: ACEIs/ARBs treatment does not raise serum levels of ACE2Valur Emilsson, Elias F Gudmundsson, Thor Aspelund, et al.
Blood|June 26, 2004
Translocation t(12;21) is related to in vitro cellular drug sensitivity to doxorubicin and etoposide in childhood acute lymphoblastic leukemiaBritt-Marie Frost, Erik Forestier, Göran Gustafsson, et al.
Blood|February 7, 2002
Precise quantification of minimal residual disease at day 29 allows identification of children with acute lymphoblastic leukemia and an excellent outcomeCharlotte Nyvold, Hans O Madsen, Lars P Ryder, et al.
Journal of Neural Transmission|January 1, 1987
Effects of acute and chronic treatment with imipramine on 5-hydroxytryptamine nerve cell groups and on bulbospinal 5-hydroxytryptamine/substance P/thyrotropin releasing hormone immunoreactive neurons in the rat. A morphometric and microdensitometric analysisI Kitayama, A M Janson, K Fuxe, et al.
European Journal of Haematology|August 23, 2011
Pneumocystis jiroveci pneumonia prophylaxis during maintenance therapy influences methotrexate/6-mercaptopurine dosing but not event-free survival for childhood acute lymphoblastic leukemiaMette Levinsen, Diana Shabaneh, Cathrine Bohnstedt, et al.
Pageof 32